Recent study has provided evidence that fatty acid synthase (FASN), a key enzyme of de novo lipid synthesis, upregulates sphingolipid metabolism to promote metastatic phenotype in colorectal cancer [78] which brings into close association de novo lipogenesis and sphingolipid metabolism in the regulation of colon cancer progression. This evidence concerns the gene FASN and colonic neoplasm.